| Metabolic syndrome, aging and involvement of oxidative stress F Bonomini, LF Rodella, R Rezzani Aging and disease 6 (2), 109, 2015 | 674 | 2015 |
| Atherosclerosis and oxidative stress F Bonomini, S Tengattini, A Fabiano, R Bianchi, R Rezzani Histology and histopathology, 2008 | 561 | 2008 |
| Melatonin as an anti-inflammatory agent modulating inflammasome activation G Favero, L Franceschetti, F Bonomini, LF Rodella, R Rezzani International journal of endocrinology 2017, 2017 | 262 | 2017 |
| Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice G Favero, A Stacchiotti, S Castrezzati, F Bonomini, M Albanese, ... Nutrition Research 35 (10), 891-900, 2015 | 110 | 2015 |
| Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling R Paroni, L Terraneo, F Bonomini, E Finati, E Virgili, P Bianciardi, ... Journal of Pineal Research 57 (1), 43-52, 2014 | 85 | 2014 |
| Beneficial effects of melatonin in protecting against cyclosporine A‐induced cardiotoxicity are receptor mediated R Rezzani, LF Rodella, F Bonomini, S Tengattini, R Bianchi, RJ Reiter Journal of pineal research 41 (3), 288-295, 2006 | 85 | 2006 |
| Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury GL Volti, V Sorrenti, P Murabito, F Galvano, M Veroux, A Gullo, ... Transplantation proceedings 39 (10), 2986-2991, 2007 | 82 | 2007 |
| Histochemical and molecular overview of the thymus as site for T-cells development R Rezzani, F Bonomini, LF Rodella Progress in histochemistry and cytochemistry 43 (2), 73-120, 2008 | 81 | 2008 |
| Aging and vascular dysfunction: beneficial melatonin effects LF Rodella, G Favero, C Rossini, E Foglio, F Bonomini, RJ Reiter, ... Age 35, 103-115, 2013 | 74 | 2013 |
| Apolipoprotein E and its role in aging and survival F Bonomini, F Filippini, T Hayek, M Aviram, S Keidar, LF Rodella, ... Experimental Gerontology 45 (2), 149-157, 2010 | 72 | 2010 |
| Promising antineoplastic actions of melatonin G Favero, E Moretti, F Bonomini, RJ Reiter, LF Rodella, R Rezzani Frontiers in pharmacology 9, 1086, 2018 | 64 | 2018 |
| Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats R Rezzani, E Porteri, C De Ciuceis, F Bonomini, LF Rodella, S Paiardi, ... Hypertension 55 (6), 1373-1380, 2010 | 63 | 2010 |
| Aquaporin and blood brain barrier. F Bonomini, R Rezzani Current neuropharmacology 8 (2), 92-96, 2010 | 61 | 2010 |
| Oral supplementation of melatonin protects against fibromyalgia-related skeletal muscle alterations in reserpine-induced myalgia rats G Favero, V Trapletti, F Bonomini, A Stacchiotti, A Lavazza, LF Rodella, ... International journal of molecular sciences 18 (7), 1389, 2017 | 59 | 2017 |
| Dietary melatonin supplementation could be a promising preventing/therapeutic approach for a variety of liver diseases F Bonomini, E Borsani, G Favero, LF Rodella, R Rezzani Nutrients 10 (9), 1135, 2018 | 57 | 2018 |
| The protective effect of caffeic acid phenethyl ester against cyclosporine A-induced cardiotoxicity in rats R Rezzani, L Giugno, B Buffoli, F Bonomini, R Bianchi Toxicology 212 (2-3), 155-164, 2005 | 52 | 2005 |
| Mitochondrial dysfunction in skeletal muscle of a fibromyalgia model: the potential benefits of melatonin G Favero, F Bonomini, C Franco, R Rezzani International journal of molecular sciences 20 (3), 765, 2019 | 48 | 2019 |
| Pineal gland tumors: a review G Favero, F Bonomini, R Rezzani Cancers 13 (7), 1547, 2021 | 46 | 2021 |
| NLRP3 inflammasome modulation by melatonin supplementation in chronic pristane-induced lupus nephritis F Bonomini, M Dos Santos, FV Veronese, R Rezzani International Journal of Molecular Sciences 20 (14), 3466, 2019 | 44 | 2019 |
| Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis M Dos Santos, PT Poletti, G Favero, A Stacchiotti, F Bonomini, ... Autoimmunity 51 (2), 69-80, 2018 | 43 | 2018 |
